Compliance-led Growth EPC Group recently promoted Luzynski to VP of Compliance, signaling a formalized regulatory program. With revenue in the 500M-1B range and 51-200 employees, EPC appears to be a strong candidate for enterprise-grade GRC, audit, and regulatory reporting solutions tailored to biotech research.

Data Security & Destruction The SSD destruction service launch and security-minded tech stack highlight ongoing data security and asset disposition needs. Prospects include secure data destruction services, data lifecycle management, and encryption or DLP solutions aligned to biotech compliance.

Expansion & IT Modernization Office relocation to Bethlehem in 2020 to accommodate rapid expansion indicates growing workloads and a need for scalable IT and facility infrastructure. Potential opportunities include network upgrades, on-site IT support, and data center or edge computing optimization for regional operations.

Digital Analytics & Privacy Piwik PRO Core usage shows a commitment to analytics with privacy considerations. Opportunities exist to augment privacy-preserving analytics, consent management, and website performance optimization to support talent acquisition and partner outreach.

Enterprise-Biotech Opportunity As a mid-to-large biotech research company with substantial revenue, EPC is a strong candidate for multi-year contracts spanning security, compliance, data management, and software modernization. A coordinated cross-sell strategy across governance, IT, and lab-facing solutions could drive high lifetime value.